No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Cardiff Oncology to Present at Upcoming Investor Conferences in May
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
HC Wainwright & Co. Reiterates Buy on Cardiff Oncology, Maintains $14 Price Target
Cardiff Oncology Analyst Ratings
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations